Search

Displaying results 191 - 200 of 384 in total
  1. Drug

    Elaeagnus angustifolia pollen

    go.drugbank.com/drugs/DB10751
    Approved

    Elaeagnus angustifolia pollen is the pollen of the Elaeagnus angustifolia plant. Elaeagnus angustifolia pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic ExtractSynonyms: Elaeagnus angustifolia pollen, Russian olive pollen extract
  2. Drug

    Alnus serrulata pollen

    go.drugbank.com/drugs/DB15509
    Approved

    Alnus serrulata pollen allergenic extract is used in allergenic testing.

    Synonyms: Alnus autumnalis pollen, Alnus latifolia pollenProducts: Hazel Alder Pollen
  3. Drug

    Prosopis velutina seed

    go.drugbank.com/drugs/DB15510
    Approved

    Prosopis velutina seed allergenic extract is used in allergenic testing.

    Products: Velvet Mesquite Pollen
  4. Drug

    Acacia

    go.drugbank.com/drugs/DB10451
    Approved

    Acacia allergenic extract is used in allergenic testing.

    Products: Acacia Pollen
  5. Drug

    Ketoconazole

    go.drugbank.com/drugs/DB01026
    ApprovedInvestigational

    Ketoconazole is an imidazole antifungal agent used in the prevention and treatment of a variety of fungal infections.[FDA Label] It functions by preventing the synthesis of ergosterol, the fungal equivalent of cholesterol, thereby increa...

    Products: KOFEN
  6. Drug

    Latanoprostene bunod

    go.drugbank.com/drugs/DB11660
    Approved

    Latanoprostene Bunod has been used in trials studying the treatment of Glaucoma, Ocular Hypertension, Open-Angle Glaucoma, Open Angle Glaucoma, and Intraocular Pressure. … As of November 2, 2017 the FDA approved Bausch + Lomb's Vyzulta (latanoprostene bunod opthalmic solution), 0.024% for the indication of reducing intraocular pressure in patients with open-angle glaucoma

  7. Drug

    Netarsudil

    go.drugbank.com/drugs/DB13931
    ApprovedInvestigational

    aqueous As of December 18, 2017 the FDA approved Aerie Pharmaceutical's Rhopressa (netarsudil ophthalmic solution) 0.02% for the indication of reducing elevated intraocular pressure in patients with open-angle

  8. Drug

    Dorzolamide

    go.drugbank.com/drugs/DB00869
    ApprovedInvestigational

    Dorzolamide is a non-bacteriostatic sulfonamide derivative [A1304] and topical carbonic anhydrase (CA) inhibitor that treats elevated intraocular pressure (IOP) associated with open-angle glaucoma and

  9. Drug

    Travoprost

    go.drugbank.com/drugs/DB00287
    ApprovedInvestigational

    It is used to decrease intraocular pressure in open-angle glaucoma and ocular hypertension.

  10. Drug

    Timolol

    go.drugbank.com/drugs/DB00373
    ApprovedInvestigational

    [L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.